These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26761268)

  • 21. Immunosenescent CD57+CD4+ T-cells accumulate and contribute to interferon-γ responses in HIV patients responding stably to ART.
    Fernandez S; French MA; Price P
    Dis Markers; 2011; 31(6):337-42. PubMed ID: 22182806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The chemokine receptor CX3CR1 controls homing and anti-viral potencies of CD8 effector-memory T lymphocytes in HIV-infected patients.
    Combadière B; Faure S; Autran B; Debré P; Combadière C
    AIDS; 2003 Jun; 17(9):1279-90. PubMed ID: 12799549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cells.
    Daucher M; Price DA; Brenchley JM; Lamoreaux L; Metcalf JA; Rehm C; Nies-Kraske E; Urban E; Yoder C; Rock D; Gumkowski J; Betts MR; Dybul MR; Douek DC
    J Virol; 2008 Apr; 82(8):4102-14. PubMed ID: 18234797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive association between beta-chemokine-producing T cells and HIV type 1 viral load in HIV-infected subjects in Abidjan, Côte d'Ivoire.
    Jennes W; Sawadogo S; Koblavi-Dème S; Vuylsteke B; Maurice C; Roels TH; Chorba T; Nkengasong JN; Kestens L
    AIDS Res Hum Retroviruses; 2002 Feb; 18(3):171-7. PubMed ID: 11839151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
    Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP
    Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcome of HIV viraemic controllers and noncontrollers with normal CD4 counts is exclusively determined by antigen-specific CD8+ T-cell-mediated HIV suppression.
    Tansiri Y; Rowland-Jones SL; Ananworanich J; Hansasuta P
    PLoS One; 2015; 10(3):e0118871. PubMed ID: 25764310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expansion of CD57 and CD62L-CD45RA+ CD8 T lymphocytes correlates with reduced viral plasma RNA after primary HIV infection.
    Lieberman J; Trimble LA; Friedman RS; Lisziewicz J; Lori F; Shankar P; Jessen H
    AIDS; 1999 May; 13(8):891-9. PubMed ID: 10371169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-specific T-cell responses detected in the genital tract of chronically HIV-infected women are largely monofunctional.
    Bere A; Denny L; Naicker P; Burgers WA; Passmore JA
    Immunology; 2013 Jul; 139(3):342-51. PubMed ID: 23374084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines.
    Kinter AL; Ostrowski M; Goletti D; Oliva A; Weissman D; Gantt K; Hardy E; Jackson R; Ehler L; Fauci AS
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14076-81. PubMed ID: 8943063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An altered cytotoxic program of CD8+ T-cells in HIV-infected patients despite HAART-induced viral suppression.
    Perdomo-Celis F; Velilla PA; Taborda NA; Rugeles MT
    PLoS One; 2019; 14(1):e0210540. PubMed ID: 30625227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD8 T-cells from most HIV-infected patients lack ex vivo HIV-suppressive capacity during acute and early infection.
    Lécuroux C; Girault I; Chéret A; Versmisse P; Nembot G; Meyer L; Rouzioux C; Pancino G; Venet A; Sáez-Cirión A;
    PLoS One; 2013; 8(3):e59767. PubMed ID: 23555774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses.
    Sáez-Cirión A; Sinet M; Shin SY; Urrutia A; Versmisse P; Lacabaratz C; Boufassa F; Avettand-Fènoël V; Rouzioux C; Delfraissy JF; Barré-Sinoussi F; Lambotte O; Venet A; Pancino G;
    J Immunol; 2009 Jun; 182(12):7828-37. PubMed ID: 19494307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noncytolytic inhibition of X4 virus by bulk CD8(+) cells from human immunodeficiency virus type 1 (HIV-1)-infected persons and HIV-1-specific cytotoxic T lymphocytes is not mediated by beta-chemokines.
    Geiben-Lynn R; Kursar M; Brown NV; Kerr EL; Luster AD; Walker BD
    J Virol; 2001 Sep; 75(17):8306-16. PubMed ID: 11483776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secretion of MIP-1β and MIP-1α by CD8(+) T-lymphocytes correlates with HIV-1 inhibition independent of coreceptor usage.
    Saunders KO; Ward-Caviness C; Schutte RJ; Freel SA; Overman RG; Thielman NM; Cunningham CK; Kepler TB; Tomaras GD
    Cell Immunol; 2011; 266(2):154-64. PubMed ID: 21030011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of the capacity of elite suppressor CD4+ and CD8+ T cells to inhibit HIV-1 replication in monocyte-derived macrophages.
    Walker-Sperling VE; Buckheit RW; Blankson JN
    J Virol; 2014 Sep; 88(17):9789-98. PubMed ID: 24942573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partial recovery of senescence and differentiation disturbances in CD8
    Eberhard JM; Ahmad F; Hong HS; Bhatnagar N; Keudel P; Schulze Zur Wiesch J; Schmidt RE; Meyer-Olson D
    Clin Exp Immunol; 2016 Nov; 186(2):227-238. PubMed ID: 27377704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy.
    Chiu CY; Chang JJ; Dantanarayana AI; Solomon A; Evans VA; Pascoe R; Gubser C; Trautman L; Fromentin R; Chomont N; McMahon JH; Cameron PU; Rasmussen TA; Lewin SR
    J Immunol; 2022 Jan; 208(1):54-62. PubMed ID: 34853078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD8+ T-cell-mediated suppression of HIV-1 long terminal repeat-driven gene expression is not modulated by the CC chemokines RANTES, macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta.
    Leith JG; Copeland KF; McKay PJ; Richards CD; Rosenthal KL
    AIDS; 1997 Apr; 11(5):575-80. PubMed ID: 9108938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher Body Mass Index Is Associated With Greater Proportions of Effector CD8+ T Cells Expressing CD57 in Women Living With HIV.
    Reid MJA; Baxi SM; Sheira LA; Landay AL; Frongillo EA; Adedimeji A; Cohen MH; Wentz E; Gustafson DR; Merenstein D; Hunt PW; Tien PC; Weiser SD;
    J Acquir Immune Defic Syndr; 2017 Aug; 75(5):e132-e141. PubMed ID: 28328551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alpha.
    Lichterfeld M; Yu XG; Waring MT; Mui SK; Johnston MN; Cohen D; Addo MM; Zaunders J; Alter G; Pae E; Strick D; Allen TM; Rosenberg ES; Walker BD; Altfeld M
    Blood; 2004 Jul; 104(2):487-94. PubMed ID: 15059848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.